References
- Gunven, P.; Klein, G.; Henle, G.; Henle, W.; Clifford, P. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients. Nature 1970, 228 (276), 1053–1056. [PUBMED], [INFOTRIEVE]
- Chien, Y C.; Chen, J Y.; Liu, M Y.; Yang, H I.; Hsu, M M.; Chen, C J.; Yang, C S. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N. Engl. J. Med. 2001, 345 (26), 1877–1882. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hoe, J W. Computed tomography of nasopharyngeal carcinoma. A review of CT appearances in 56 patients. Eur. J. Radiol. 1989, 9 (2), 83–90. [PUBMED], [INFOTRIEVE]
- King, A D.; Ahuja, A T.; Leung, S F.; Lam, W W.; Teo, P.; Chan, Y L.; Metreweli, C. Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck 2000, 22 (3), 275–281. [PUBMED], [INFOTRIEVE]
- Tsao, S Y.; Shiu, W C. Radiotherapy and chemotherapy for nasopharyngeal carcinoma. Ear Nose Throat. J. 1990, 69 (4), 272–278. [PUBMED], [INFOTRIEVE]
- Chan, A T.; Teo, P M.; Leung, T W.; Johnson, P J. The role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer 1998, 82 (6), 1003–1012. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Merino, O R.; Lindberg, R D.; Fletcher, G H. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1977, 40 (1), 145–151. [PUBMED], [INFOTRIEVE]
- Cheng, S H.; Yen, K L.; Jian, J J.; Tsai, S Y.; Chu, N M.; Leu, S Y.; Chan, K Y.; Tan, T D.; Cheng, J C.; Hsieh, C Y.; Huang, A T. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. Int. J. Radiat. Oncol. Biol. Phys. 2001, 50 (3), 717–726. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Teo, P.; Shiu, W.; Leung, S F.; Lee, W Y. Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography—an analysis of 659 patients. Radiother. Oncol. 1992, 23 (2), 79–93. [PUBMED], [INFOTRIEVE]
- Lin, J C.; Jan, J S.; Hsu, C Y. Outpatient weekly chemotherapy in patients with nasopharyngeal carcinoma and distant metastasis. Cancer 1998, 83 (4), 635–640. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gebbia, V.; Zerillo, G.; Restivo, G.; Speciale, R.; Cupido, G.; Lo, Bue, P.; Ingria, F.; Gallina, S.; Spatafora, G.; Testa, A. Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases. Br. J. Cancer 1993, 68 (1), 191–194. [PUBMED], [INFOTRIEVE]
- Nabhan, C.; Krett, N.; Gandhi, V.; Rosen, S. Gemcitabine in hematologic malignancies. Curr. Opin. Oncol. 2001, 13 (6), 514–521. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Carmichael, J. The role of gemcitabine in the treatment of other tumours. Br. J. Cancer 1998, 78 (Suppl. 3), 21–25. [PUBMED], [INFOTRIEVE]
- Braakhuis, B J.M.; Ruiz, van Haperen, V W.T.; Welters, M J.P.; Peters, G J. Schedule-dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenografts. Eur. J. Cancer 1995, 31A (13–14), 2335–2340. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Huisman, C.; Giaccone, G.; van Groeningen, C J.; Sutedja, G.; Postmus, P E.; Smit, E F. Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling. Lung Cancer 2001, 33 (2–3), 267–275. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Philip, P A.; Zalupski, M M.; Vaitkevicius, V K.; Arlauskas, P.; Chaplen, R.; Heilbrun, L K.; Adsay, V.; Weaver, D.; Shields, A F. Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma. Cancer 2001, 92 (3), 569–577. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Peters, G J.; Bergman, A M.; Ruiz, van Haperen, V W.; Veerman, G.; Kuiper, C M.; Braakhuis, B J. Interaction between cisplatin andgemcitabine in vitro and in vivo. Semin. Oncol. 1995, 22 (4 Suppl. 11), 72–79. [PUBMED], [INFOTRIEVE]
- Van Moorsel, C J.; Pinedo, H M.; Veerman, G.; Bergman, A M.; Kuiper, C M.; Vermorken, J B.; van der Vijgh, W J.; Peters, G J. Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines. Br. J. Cancer 1999, 80 (7), 981–990. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lund, B.; Neijt, J P. Gemcitabine in cisplatin-resistant ovarian cancer. Semin. Oncol. 1996, 23 (5 Suppl. 10), 72–76. [PUBMED], [INFOTRIEVE]
- Ma, B B.; Tannock, I F.; Pond, G R.; Edmonds, M R.; Siu, L L. Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma. Cancer 2002, 95 (12), 2516–2523. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Foo, K F.; Tan, E H.; Leong, S S.; Wee, J T.; Tan, T.; Fong, K W.; Koh, L.; Tai, B C.; Lian, L G.; Machin, D. Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type. Ann. Oncol. 2002, 13 (1), 150–156. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ngan, R K.; Yiu, H H.; Lau, W H.; Yau, S.; Cheung, F Y.; Chan, T M.; Kwok, C H.; Chiu, C Y.; Au, S K.; Foo, W.; Law, C K.; Tse, K C. Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study. Ann. Oncol. 2002, 13 (8), 1252–1258. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Soto Parra, H.; Cavina, R.; Latteri, F.; Sala, A.; Dambrosio, M.; Antonelli, G.; Morenghi, E.; Alloisio, M.; Ravasi, G.; Santoro, A. Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study. Ann. Oncol. 2002, 13 (7), 1080–1086. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Choo, R.; Tannock, I. Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. Cancer 1991, 68 (10), 2120–2124. [PUBMED], [INFOTRIEVE]
- Dugan, M.; Choy, D.; Ngai, A.; Sham, J.; Choi, P.; Shiu, W.; Leung, T.; Leung, T.; Teo, P.; Prasad, U.; Lee, S. Multicenter phase II trial of mitoxantrone in patients with advanced nasopharyngeal carcinoma in Southeast Asia: an Asian-Oceanian Clinical Oncology Association Group study. J. Clin. Oncol. 1993, 11 (1), 70–76. [PUBMED], [INFOTRIEVE]
- Boussen, H.; Cvitkovic, E.; Wendling, J L.; Azli, N.; Bachouchi, M.; Mahjoubi, R.; Kalifa, C.; Wibault, P.; Schwaab, G.; Armand, J P. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin; bleomycin; and fluorouracil. J. Clin. Oncol. 1991, 9 (9), 1675–1681. [PUBMED], [INFOTRIEVE]
- Teo, P M.; Kwan, W H.; Lee, W Y.; Leung, S F.; Johnson, P J. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 1996, 77 (12), 2423–2431. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hui, E P.; Leung, S F.; Au, J S.; Zee, B.; Tung, S.; Chua, D.; Sze, W M.; Law, C K.; Leung, T W.; Chan, A T. Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong nasopharyngeal carcinoma study group. Cancer 2004, 101 (2), 300–306. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kurnianda, J.; Pardjono, E.; Adiwiyono, A.; Purwanto, I.; Hariwiyanto, B.; Haryadi, B.; Kusumo, H.; Rahardjo, B.; Buter, J.; Giaccone, G. Combination of gemcitabine and cisplatin (GC) chemotherapy for advanced or recurrent nasopharyngeal cancer (NPC): a phase II study. J. Clin. Oncol. 2004, 22 (14S), 5577, (Meeting Abstracts).
- Zhang, L.; Guan, Z Z.; Zhang, Y. Phase II study of gemcitabine single agent for patients with advanced nasopharyngeal carcinoma (NPC) who failed to first line platinum-based chemotherapy. J. Clin. Oncol. 2004, 22 (14S), 5612, (Meeting Abstracts).